FDA drug alerts in pulmonology, including drug approvals/warnings, vaccine approvals, medical device recalls/updates, and ...
The Food and Drug Administration (FDA) recently issued warning letters to two third-party nonclinical testing laboratories.
The approval marks first indication for Keytruda in MPM in the US, MPM is a rare, aggressive cancer around the lining of the lungs and chest Wednesday, the FDA approved Merck & Co Inc’s MRK ...
Wednesday, the FDA approved Merck & Co Inc’s (NYSE:MRK) Keytruda (pembrolizumab) in combination with pemetrexed and platinum chemotherapy for the first-line treatment of adult patients with ...
The FDA has cleared the Epitomee capsule to support weight management in adults with a body mass index of 25 to 40kg/m2.
KONFIDENT phase 3 trial results demonstrated significantly faster symptom relief with sebetralstat compared to placebo.
Cannabis (Cannabis sativa) is an herbal drug. It contains chemicals called cannabinoids, including delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). The cannabinoids in cannabis work by ...
The FDA has declined to approve Vanda Pharma's tradipitant for delayed gastric emptying (gastroparesis), prompting a furious response from the company. The success of clinical trials hinges on a ...
The report for Congress specifies that lawmakers would need to help shape which products are allowed, and in what form.
Read need-to-know updates, commentary, and analysis on International Trade issues written by leading professionals.
Keytruda is already approved in more than 40 different oncology indications, but its latest label expansion is a first for the cancer blockbuster.
There is still time to submit a meeting request for FDA consideration in the CID Paired Meeting Program. September 30th and December 31st are the last 2 slots in 2024. We can help you take ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback